{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:44:50Z","timestamp":1784616290763,"version":"3.55.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012264","name":"NIH","doi-asserted-by":"publisher","award":["R01NS082283"],"award-info":[{"award-number":["R01NS082283"]}],"id":[{"id":"10.13039\/501100012264","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sanford Research and Charles River Laboratories"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neurobiology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.pneurobio.2020.101789","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:59:28Z","timestamp":1584493168000},"page":"101789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["A multimodal approach to identify clinically relevant biomarkers to comprehensively monitor disease progression in a mouse model of pediatric neurodegenerative disease"],"prefix":"10.1016","volume":"189","author":[{"given":"Tyler B.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon J.","family":"Brudvig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimmo K.","family":"Lehtim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob T.","family":"Cain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8634-0297","authenticated-orcid":false,"given":"Timo","family":"Bragge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Rytk\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7905-1043","authenticated-orcid":false,"given":"Tuulia","family":"Huhtala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Timm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0768-0398","authenticated-orcid":false,"given":"Maria","family":"Vihma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka T.","family":"Puoliv\u00e4li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pekka","family":"Poutiainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Nurmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill M.","family":"Weimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2134","key":"10.1016\/j.pneurobio.2020.101789_bib0005","article-title":"Exploring patterns enriched in a dataset with contrastive principal component analysis","volume":"9","author":"Abid","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0010","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1177\/0883073813494813","article-title":"Neurobehavioral features and natural history of juvenile neuronal ceroid lipofuscinosis (Batten disease)","volume":"28","author":"Adams","year":"2013","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0015","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.bbadis.2012.11.014","article-title":"Human pathology in NCL","volume":"1832","author":"Anderson","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Mol. Basis of Dis."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0887-8994(92)90032-T","article-title":"Jansky-Bielschowsky variant disease: CT, MRI, and SPECT findings","volume":"8","author":"Autti","year":"1992","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0025","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00019052-199712000-00015","article-title":"Magnetic resonance techniques in neuronal ceroid lipofuscinoses and some other lysosomal diseases affecting the brain","volume":"10","author":"Autti","year":"1997","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0030","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3174\/ajnr.A4978","article-title":"MRI brain volume measurements in infantile neuronal ceroid lipofuscinosis","volume":"38","author":"Baker","year":"2017","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0035","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ana.410380304","article-title":"Aging, energy, and oxidative stress in neurodegenerative diseases","volume":"38","author":"Beal","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0166-2236(93)90117-5","article-title":"Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?","volume":"16","author":"Beal","year":"1993","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF01273267","article-title":"Loss of pigment-laden stellate cells: a severe alteration of the isocortex in juvenile neuronal ceroid-lipofuscinosis","volume":"42","author":"Braak","year":"1978","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0050","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/(SICI)1096-8628(19980526)77:4<289::AID-AJMG8>3.0.CO;2-I","article-title":"Neuronal ceroid lipofuscinosis (nclf), a new disorder of the mouse linked to chromosome 9","volume":"77","author":"Bronson","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0055","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1038\/s41598-017-03336-1","article-title":"A translational approach to capture gait signatures of neurological disorders in mice and humans","volume":"7","author":"Broom","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.nbd.2007.08.007","article-title":"Identification of alpha-fetoprotein as an autoantigen in juvenile Batten disease","volume":"29","author":"Castaneda","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0065","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/hmg\/11.12.1421","article-title":"An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease","volume":"11","author":"Chattopadhyay","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0070","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1212\/01.WNL.0000041913.97883.8B","article-title":"An autoantibody to GAD65 in sera of patients with juvenile neuronal ceroid lipofuscinoses","volume":"59","author":"Chattopadhyay","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2007.12.004","article-title":"Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair","volume":"118","author":"Chen","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0080","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1042\/BST0381448","article-title":"The neuronal ceroid lipofuscinoses: the same, but different?","volume":"38","author":"Cooper","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0085","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bbadis.2006.08.002","article-title":"Progress towards understanding disease mechanisms in small vertebrate models of neuronal ceroid lipofuscinosis","volume":"1762","author":"Cooper","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0090","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.parkreldis.2013.10.015","article-title":"Freezing of gait\u2014first motor manifestation in late infantile variant neuronal ceroid lipofuscinosis","volume":"20","author":"Damasio","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0095","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1177\/0883073813493665","article-title":"Batten disease: clinical aspects, molecular mechanisms, translational science, and future directions","volume":"28","author":"Dolisca","year":"2013","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0100","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ymgme.2016.07.011","article-title":"Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): expert recommendations for early detection and laboratory diagnosis","volume":"119","author":"Fietz","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1750-3639.2004.tb00499.x","article-title":"Current state of clinical and morphological features in human NCL","volume":"14","author":"Goebel","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00316269","article-title":"Ultrastructural investigations of peripheral nerves in neuronal ceroid-lipofuscinoses (NCL)","volume":"213","author":"Goebel","year":"1976","journal-title":"J. Neurol."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0115","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ejpn.2013.04.011","article-title":"CLN6 disease caused by the same mutation originating in Pakistan has varying pathology","volume":"17","author":"Guerreiro","year":"2013","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0120","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/febs.13593","article-title":"Plasma biomarkers for neuronal ceroid lipofuscinosis","volume":"283","author":"Hersrud","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0125","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/wics.101","article-title":"Principal component analysis","volume":"2","author":"Herv\u00e9","year":"2010","journal-title":"Wiley Interdiscip. Rev. Comput. Stat."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0130","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1212\/WNL.55.4.579","article-title":"Phenotype-genotype correlation in eight patients with Finnish variant late infantile NCL (CLN5)","volume":"55","author":"Holmberg","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0135","series-title":"Principal Component Analysis","author":"Joliffe","year":"2002"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0140","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1242\/dmm.024547","article-title":"Using the mouse to model human disease: increasing validity and reproducibility","volume":"9","author":"Justice","year":"2016","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0145","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1242\/bio.20134804","article-title":"Altered biometal homeostasis is associated with CLN6 mRNA loss in mouse neuronal ceroid lipofuscinosis","volume":"2","author":"Kanninen","year":"2013","journal-title":"Biol. Open"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0150","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1750-3639.2006.00002.x","article-title":"Activation of non-neuronal cells within the prenatal developing brain of sheep with neuronal ceroid lipofuscinosis","volume":"16","author":"Kay","year":"2006","journal-title":"Brain Pathol."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0155","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.neuint.2009.07.012","article-title":"Neuropeptide changes and neuroactive amino acids in CSF from humans and sheep with neuronal ceroid lipofuscinoses (NCLs, Batten disease)","volume":"55","author":"Kay","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0160","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1093\/hmg\/ddp355","article-title":"Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease","volume":"18","author":"Kielar","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0165","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1399-0004.2009.01214.x","article-title":"An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients","volume":"76","author":"Kohan","year":"2009","journal-title":"Clin. Genet."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0170","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.bbadis.2015.05.003","article-title":"The neuronal ceroid lipofuscinoses program: a translational research experience in Argentina","volume":"1852","author":"Kohan","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0175","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1177\/0883073813494479","article-title":"Regional brain atrophy in mouse models of neuronal ceroid lipofuscinosis: a new rostrocaudal perspective","volume":"28","author":"Kuhl","year":"2013","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0180","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1055\/s-2007-973754","article-title":"Brain perfusion SPECT in juvenile neuronal ceroid lipofuscinosis","volume":"27","author":"Launes","year":"1996","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0185","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1212\/WNL.52.2.360","article-title":"Delayed classic and protracted phenotypes of compound heterozygous juvenile neuronal ceroid lipofuscinosis","volume":"52","author":"Lauronen","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0190","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2119\/molmed.2010.00241","article-title":"Analysis of potential biomarkers and modifier genes affecting the clinical course of CLN3 disease","volume":"17","author":"Lebrun","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0195","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-2007-973674","article-title":"Brain perfusion SPECT abnormalities in neuronal ceroid lipofuscinoses","volume":"28","author":"Liewendahl","year":"1997","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0200","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1212\/01.wnl.0000169019.41332.8a","article-title":"A clinical rating scale for Batten disease: reliable and relevant for clinical trials","volume":"65","author":"Marshall","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0205","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s10354-015-0359-4","article-title":"Congenital CLN disease in two siblings","volume":"165","author":"Meyer","year":"2015","journal-title":"Wien. Med. Wochenschr."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0210","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/0883073813494268","article-title":"Classification and natural history of the neuronal ceroid lipofuscinoses","volume":"28","author":"Mink","year":"2013","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pneurobio.2006.12.003","article-title":"N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology","volume":"81","author":"Moffett","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0220","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","article-title":"Genetics of the neuronal ceroid lipofuscinoses (Batten disease)","volume":"1852","author":"Mole","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078694","article-title":"A murine model of variant late infantile ceroid lipofuscinosis recapitulates behavioral and pathological phenotypes of human disease","volume":"8","author":"Morgan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0230","doi-asserted-by":"crossref","first-page":"e78694","DOI":"10.1371\/journal.pone.0078694","article-title":"A murine model of variant late infantile ceroid lipofuscinosis recapitulates behavioral and pathological phenotypes of human disease","volume":"8","author":"Morgan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0235","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000334838","article-title":"Evaluation of neurodegeneration in a mouse model of infantile batten disease by magnetic resonance imaging and magnetic resonance spectroscopy","volume":"9","author":"Munasinghe","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0240","unstructured":"NIH, N.C.f.A.T.S. https:\/\/rarediseases.info.nih.gov\/diseases\/pages\/31\/faqs-about-rare-diseases (2017)."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0245","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.nec.2010.12.004","article-title":"An introduction to diffusion tensor image analysis","volume":"22","author":"O\u2019Donnell","year":"2011","journal-title":"Neurosurg. Clin. N. Am."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0250","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nbd.2005.01.025","article-title":"Glial activation spreads from specific cerebral foci and precedes neurodegeneration in presymptomatic ovine neuronal ceroid lipofuscinosis (CLN6)","volume":"20","author":"Oswald","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0255","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.nbd.2008.06.004","article-title":"Location and connectivity determine GABAergic interneuron survival in the brains of South Hampshire sheep with CLN6 neuronal ceroid lipofuscinosis","volume":"32","author":"Oswald","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0260","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40478-017-0476-y","article-title":"Glial cells are functionally impaired in juvenile neuronal ceroid lipofuscinosis and detrimental to neurons","volume":"5","author":"Parviainen","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"issue":"Pt 5","key":"10.1016\/j.pneurobio.2020.101789_bib0265","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/brain\/117.5.1085","article-title":"Spielmeyer-Vogt (Batten, Spielmeyer-Sjogren) disease. Distinctive patterns of cerebral glucose utilization","volume":"117","author":"Philippart","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0270","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13023-019-0994-8","article-title":"Tracking sex-dependent differences in a mouse model of CLN6-Batten disease","volume":"14","author":"Poppens","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0275","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.bbadis.2015.05.007","article-title":"Human NCL neuropathology","volume":"1852","author":"Radke","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0280","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ajmg.1320310606","article-title":"Batten disease: past, present, and future","volume":"5","author":"Rider","year":"1988","journal-title":"Am. J. Med. Genet. Suppl."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0285","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1055\/s-2002-33677","article-title":"Positron emission tomography shows reduced striatal dopamine D1 but not D2 receptors in juvenile neuronal ceroid lipofuscinosis","volume":"33","author":"Rinne","year":"2002","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0290","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/jnnp.62.6.622","article-title":"[18F]fluorodopa PET shows striatal dopaminergic dysfunction in juvenile neuronal ceroid lipofuscinosis","volume":"62","author":"Ruottinen","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0295","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10858-011-9491-7","article-title":"A metabolomic comparison of mouse models of the Neuronal Ceroid Lipofuscinoses","volume":"49","author":"Salek","year":"2011","journal-title":"J. Biomol. NMR"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0300","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0387-7604(88)80075-5","article-title":"Neuronal ceroid-lipofuscinoses in childhood","volume":"10","author":"Santavuori","year":"1988","journal-title":"Brain Dev."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0305","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1567-424X(09)70193-X","article-title":"Neuronal ceroid lipofuscinoses in childhood","volume":"53","author":"Santavuori","year":"2000","journal-title":"Suppl. Clin. Neurophysiol."},{"issue":"Suppl A","key":"10.1016\/j.pneurobio.2020.101789_bib0310","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/ejpn.2000.0454","article-title":"Clinical and neuroradiological diagnostic aspects of neuronal ceroid lipofuscinoses disorders","volume":"5","author":"Santavuori","year":"2001","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0315","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF02996301","article-title":"Comparison of brain perfusion SPECT and MRI findings in children with neuronal ceroid-lipofuscinosis and in their families","volume":"16","author":"Sayit","year":"2002","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0320","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S1090-3798(15)30049-0","article-title":"OP48 \u2013 2893: the DEM-CHILD NCL patient database: a tool for the evaluation of therapies in neuronal ceroid lipofuscinoses (NCL)","volume":"19","author":"Schulz","year":"2015","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0325","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0966-6362(99)00047-8","article-title":"An index for quantifying deviations from normal gait","volume":"11","author":"Schutte","year":"2000","journal-title":"Gait Posture"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0330","first-page":"1373","article-title":"MR imaging and localized proton MR spectroscopy in late infantile neuronal ceroid lipofuscinosis","volume":"19","author":"Seitz","year":"1998","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0335","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1021\/acs.jproteome.7b00460","article-title":"Proteomic analysis of brain and cerebrospinal fluid from the three major forms of neuronal ceroid lipofuscinosis reveals potential biomarkers","volume":"16","author":"Sleat","year":"2017","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0340","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nmeth.2935","article-title":"Olfactory exposure to males, including men, causes stress and related analgesia in rodents","volume":"11","author":"Sorge","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0345","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ajmg.10660","article-title":"Late infantile neuronal ceroid lipofuscinosis: quantitative description of the clinical course in patients with CLN2 mutations","volume":"112","author":"Steinfeld","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0350","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/a4b06d46-8eb9-4d15-a15a-41bf4b5ccb8b","article-title":"Disruption of the autophagy-lysosome pathway is involved in neuropathology of the nclf mouse model of neuronal ceroid lipofuscinosis","volume":"7","author":"Thelen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0355","volume":"13","author":"Timm","year":"2018"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201470","article-title":"Searching for novel biomarkers using a mouse model of CLN3-Batten disease","volume":"13","author":"Timm","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0365","series-title":"ClinicalTrials.gov","author":"US National Library of Medicine","year":"2016"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0370","first-page":"1443","article-title":"Early differential diagnosis of infantile neuronal ceroid lipofuscinosis, Rett syndrome, and Krabbe disease by CT and MR","volume":"15","author":"Vanhanen","year":"1994","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0375","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1055\/s-2007-973753","article-title":"Brain perfusion SPECT in infantile neuronal ceroid-lipofuscinosis (INCL). Comparison with clinical manifestations and MRI findings","volume":"27","author":"Vanhanen","year":"1996","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0380","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2004-815788","article-title":"Neuroradiological findings (MRS, MRI, SPECT) in infantile neuronal ceroid-lipofuscinosis (infantile CLN1) at different stages of the disease","volume":"35","author":"Vanhanen","year":"2004","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0385","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1055\/s-0037-1613681","article-title":"Congenital neuronal ceroid lipofuscinosis with a novel CTSD gene mutation: a rare cause of neonatal-onset neurodegenerative disorder","volume":"49","author":"Varvagiannis","year":"2018","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0390","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4103\/0972-2327.112500","article-title":"Late infantile neuronal ceroid lipofuscinosis: a case report with review of literature","volume":"16","author":"Verma","year":"2013","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0395","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.bbadis.2010.04.009","article-title":"Mouse models in neurological disorders: applications of non-invasive imaging","volume":"1802","author":"Waerzeggers","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0400","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.nbd.2005.11.008","article-title":"Visual deficits in a mouse model of Batten disease are the result of optic nerve degeneration and loss of dorsal lateral geniculate thalamic neurons","volume":"22","author":"Weimer","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0405","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainres.2009.02.009","article-title":"Cerebellar defects in a mouse model of juvenile neuronal ceroid lipofuscinosis","volume":"1266","author":"Weimer","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0410","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.bbadis.2006.07.001","article-title":"Diagnosis of the neuronal ceroid lipofuscinoses: an update","volume":"1762","author":"Williams","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0415","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/01.wnl.0000267885.47092.40","article-title":"Neurological deterioration in late infantile neuronal ceroid lipofuscinosis","volume":"69","author":"Worgall","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pneurobio.2020.101789_bib0420","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.wad.0000213809.12553.fc","article-title":"Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging","volume":"20","author":"Zhu","year":"2006","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.pneurobio.2020.101789_bib0425","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nmeth.1484","article-title":"Profiling locomotor recovery: comprehensive quantification of impairments after CNS damage in rodents","volume":"7","author":"Zorner","year":"2010","journal-title":"Nat. Methods"}],"container-title":["Progress in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008220300447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008220300447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T04:03:53Z","timestamp":1759550633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301008220300447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":85,"alternative-id":["S0301008220300447"],"URL":"https:\/\/doi.org\/10.1016\/j.pneurobio.2020.101789","relation":{},"ISSN":["0301-0082"],"issn-type":[{"value":"0301-0082","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multimodal approach to identify clinically relevant biomarkers to comprehensively monitor disease progression in a mouse model of pediatric neurodegenerative disease","name":"articletitle","label":"Article Title"},{"value":"Progress in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pneurobio.2020.101789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101789"}}